entecavir 0.5 MG Oral Tablet
1 INDICATIONS AND USAGE Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. The following points should be considered when initiating therapy with entecavir: • In adult patients, this indication is based on clinical trial data in nucleoside-inhibitor-treatment-naïve and lamivudine-resistant subjects with HBeAg-positive and HBeAg-negative HBV infection and compensated liver disease and a more limited number of subjects with decompensated liver disease. [see Clinical Studies (14.1) ]. Pediatric use information is approved for Bristol-Myers Squibb Company’s Baraclude® (entecavir) tablets. However, due to Bristol-Myers Squibb Company’s marketing exclusivity rights, this drug product is not labeled with that information. Entecavir is a Hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. (1)
golden state medical supply, inc.
ROUND WHITE 0 5
0 5 ROUND WHITE
Related Pills
clonazepam 0.5 mg
aurobindo pharma limited
clonazepam 0.5 mg
aurobindo pharma limited
clonazepam 0.5 mg
aurobindo pharma limited
clonazepam 0.5 mg
aurobindo pharma limited
oxaydo oxycodone hydrochloride 5 mg
zyla life sciences us inc.
Methylphenidate Hydrochloride 10 MG Oral Tablet
Watson Laboratories, Inc.
Trazodone Hydrochloride 150 MG Oral Tablet
Pliva Inc.
amlodipine as amlodipine besylate 5 MG Oral Tablet
Greenstone LLC
sertraline as sertraline hydrochloride 50 MG Oral Tablet
Greenstone LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Entecavir tablets USP are available in the following strengths and configurations of bottles with child-resistant closures: Product Strength and Dosage Form Description Quantity NDC Number 0.5 mg film-coated tablet round, white to off-white, coated tablets, debossed with '0.5' on one side and plain on the reverse 30 tablets 51407-064-30 1 mg film-coated tablet round, pink, coated tablets, debossed with '1' on one side and plain on the reverse 30 tablets 51407-065-30 Storage Entecavir tablets USP should be stored in a tightly closed container at 25° C (77° F); excursions permitted between 15° C to 30° C (59° F to 86° F) [see USP Controlled Room Temperature]. Protect from light.
More pills like ROUND 0 5